Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis in Patients with Type 2 Diabetes Using Quantitative Perfusion MRI

被引:1
|
作者
Bernard, Monique [1 ,2 ]
Kober, Frank [1 ]
机构
[1] Aix Marseille Univ, CNRS, CRMBM, Marseille, France
[2] CRMBM, 27 Blvd Jean Moulin, F-13385 Marseille, France
关键词
myocardial blood flow; myocardial fibrosis; quantitative myocardial perfusion; type 2 diabetes mellitus;
D O I
10.1002/jmri.29346
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Imaging techniques that quantitatively and automatically measure changes in the myocardial microcirculation in patients with diabetes are lacking. Purpose: To detect diabetic myocardial microvascular complications using a novel automatic quantitative perfusion MRI technique, and to explore the relationship between myocardial microcirculation dysfunction and fibrosis. Study Type: Prospective. Subjects: 101 patients with type 2 diabetes mellitus (T2DM) (53 without and 48 with complications), 20 healthy volunteers. Field Strength/Sequence: 3.0T; modified Look-Locker inversion-recovery sequence; saturation recovery sequence and dual-bolus technique; segmented fast low-angle shot sequence. Assessment: All participants underwent MRI to determine the rest myocardial blood flow (MBF), stress MBF, myocardial perfusion reserve (MPR), and extracellular volume (ECV), which represents the extent of myocardial fibrosis. Statistical Tests: Kolmogorov–Smirnov test, Shapiro–Wilk test, Kruskal–Wallis H test, Mann–Whitney U test, chi-square test, Spearman correlation coefficient, multivariable linear regression analysis. P < 0.05 was considered statistically significant. Results: The rest MBF was not significantly different between the T2DM without complications group (1.1, IQR: 0.9–1.3) and the control group (1.1, 1.0–1.3) (P = 1.000), but it was significantly lower in the T2DM with complications group (0.8, 0.6–1.0) than in both other groups. The stress MBF and MPR were significantly lower in the T2DM without complications group (1.9, 1.5–2.3, and 1.7, 1.4–2.1, respectively) than in the control group (3.0, 2.6–3.5, and 2.7, 2.4–3.1, respectively), and were also significantly lower in the T2DM with complications group (1.1, 0.9–1.4, and 1.4, 1.2–1.8, respectively) than in the T2DM without complications group. A decrease in MBF and MPR were significantly associated with an increase in the ECV. Data Conclusion: Quantitative perfusion MRI can evaluate myocardial microcirculation dysfunction. In T2DM, there was a significant decrease in both MBF and MPR compared to healthy controls, with the decrease being significantly different between T2DM with and without complications groups. The decrease of MBF was significantly associated with the development of myocardial fibrosis, as determined by ECV. Level of Evidence: 2. Technical Efficacy: Stage 3. © 2024 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.
引用
收藏
页码:2407 / 2408
页数:2
相关论文
共 50 条
  • [31] High-resolution quantitative spiral perfusion for microvascular coronary dysfunction detection
    Yang Yang
    Sujith Kuruvilla
    Craig H Meyer
    Frederick H Epstein
    Angela M Taylor
    Christopher M Kramer
    Michael Salerno
    Journal of Cardiovascular Magnetic Resonance, 16 (Suppl 1)
  • [32] Differentiation of Obstructive Coronary Disease and Microvascular Dysfunction Using Quantitative Cardiovascular Magnetic Resonance Perfusion Mapping
    Kotecha, Tushar
    Martinez-Naharro, Ana
    Boldrini, Michele
    Knight, Daniel
    Hawkins, Philip
    Kalra, Sundeep
    Patel, Deven
    Coghlan, John G.
    Moon, James
    Plein, Sven
    Lockie, Tim
    Rakhit, Roby
    Patel, Niket
    Xue, Hui
    Kellman, Peter
    Fontana, Marianna
    CIRCULATION, 2018, 138
  • [33] Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes
    Lautamaki, Riikka
    Borra, Ronald
    Iozzo, Patricia
    Komu, Markku
    Lehtimaki, Terho
    Salmi, Marko
    Jalkanen, Sirpa
    Airaksinen, K. E. Juhani
    Knuuti, Juhani
    Parkkola, Riitta
    Nuutila, Pirjo
    DIABETES, 2006, 55 : A330 - A330
  • [34] Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes
    Lautamaki, Riikka
    Borra, Ronald
    Iozzo, Patricia
    Komu, Markku
    Lehtimaki, Terho
    Salmi, Marko
    Jalkanen, Sirpa
    Airaksinen, K. E. Juhani
    Knuuti, Juhani
    Parkkola, Riitta
    Nuutila, Pirjo
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2006, 291 (02): : E282 - E290
  • [35] Skin microvascular dysfunction in obese patients with or without Type 2 diabetes
    Le Devehat, C
    Khodabandehlou, T
    DIABETOLOGIA, 2002, 45 : A340 - A340
  • [36] Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction
    Galli, Mattia
    Niccoli, Giampaolo
    De Maria, Gianluigi
    Brugaletta, Salvatore
    Montone, Rocco A.
    Vergallo, Rocco
    Benenati, Stefano
    Magnani, Giulia
    D'Amario, Domenico
    Porto, Italo
    Burzotta, Francesco
    Abbate, Antonio
    Angiolillo, Dominick J.
    Crea, Filippo
    NATURE REVIEWS CARDIOLOGY, 2024, 21 (05) : 283 - 298
  • [37] Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction
    Mattia Galli
    Giampaolo Niccoli
    Gianluigi De Maria
    Salvatore Brugaletta
    Rocco A. Montone
    Rocco Vergallo
    Stefano Benenati
    Giulia Magnani
    Domenico D’Amario
    Italo Porto
    Francesco Burzotta
    Antonio Abbate
    Dominick J. Angiolillo
    Filippo Crea
    Nature Reviews Cardiology, 2024, 21 : 283 - 298
  • [38] Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
    Loffler, Adrian, I
    Pan, Jonathan A.
    Balfour, Pelbreton C.
    Shaw, Peter W.
    Yang, Yang
    Nasir, Moiz
    Auger, Daniel A.
    Epstein, Frederick H.
    Kramer, Christopher M.
    Gan, Li-Ming
    Salerno, Michael
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (10): : 1584 - 1589
  • [39] MYOCARDIAL DYSFUNCTION AND METABOLIC DERANGEMENT IN TYPE 2 DIABETES: RELATIONSHIP WITH PROCOLLAGEN BIOMARKERS OF MYOCARDIAL FIBROSIS
    Jellis, Christine L.
    Sacre, Julian W.
    Haluska, Brian
    Jenkins, Carly
    Marwick, Thomas H.
    Martin, Jennifer H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E860 - E860
  • [40] Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes
    Papadogeorgos, Nikolaos Oestlund
    Bengtsson, Mattias
    Kalani, Majid
    VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 893 - 899